Total submissions: 18
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000040832 | SCV000064523 | benign | not specified | 2012-04-10 | criteria provided, single submitter | clinical testing | Val29468Val in Exon 295 of TTN: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue, is not located withi n the splice consensus sequence and has been identified in 0.7% (22/3250) of Afr ican American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS;). |
Gene |
RCV000040832 | SCV000169433 | benign | not specified | 2014-05-15 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000040832 | SCV000203674 | benign | not specified | 2016-08-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001081715 | SCV000555318 | benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000618903 | SCV000736528 | benign | Cardiovascular phenotype | 2016-01-21 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Athena Diagnostics | RCV000465115 | SCV001146547 | benign | not provided | 2018-12-27 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000465115 | SCV001473992 | likely benign | not provided | 2023-11-22 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839733 | SCV002102103 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2J | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839734 | SCV002102104 | benign | Myopathy, myofibrillar, 9, with early respiratory failure | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839735 | SCV002102105 | benign | Early-onset myopathy with fatal cardiomyopathy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839732 | SCV002102107 | benign | Tibial muscular dystrophy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000040832 | SCV002547646 | benign | not specified | 2022-05-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000465115 | SCV004150217 | likely benign | not provided | 2023-03-01 | criteria provided, single submitter | clinical testing | TTN: BP4, BP7 |
CHEO Genetics Diagnostic Laboratory, |
RCV003486611 | SCV004240189 | benign | Cardiomyopathy | 2022-12-12 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000465115 | SCV005259364 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Diagnostic Laboratory, |
RCV000465115 | SCV001740254 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000040832 | SCV001923225 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000465115 | SCV001968597 | likely benign | not provided | no assertion criteria provided | clinical testing |